Document:

Exhibit
10.6

 

SHARE
PURCHASE AGREEMENT

 

This
SHARE PURCHASE AGREEMENT (“Agreement”) is made and entered into as of March 21, 2021, by and between Finnovate Acquisition
Corp., a Cayman Islands exempted company (the “Company”), and Finnovate Sponsor L.P., a limited partnership formed
under the laws of the State of Delaware (the “Purchaser”).

 

WHEREAS,
the Purchaser desires to purchase and Company desires to issue and sell to the Purchaser Class B ordinary shares, par value of US$0.0001
per share (the “Class B Shares”), on the terms and conditions set forth below.

 

NOW,
THEREFORE, in consideration of the premises and the mutual promises herein made, and in consideration of the representations, warranties,
and covenants herein contained, the parties intending to be legally bound, hereby agree as follows:

 

1.
The Transaction. Subject to the terms and conditions set forth in this Agreement, on a closing date to be agreed between the parties
hereto, Purchaser will purchase from the Company, and the Company will issue and sell to the Purchaser, 4,312,500 Class B Shares (the
“Purchased Shares”) for an aggregate purchase price of $25,000.

 

2.
Representations and Warranties of the Company.

 

The
Company hereby represents and warrants to the Purchaser as follows:

 

2.1.
The Company (i) is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands,
and has full power and authority to own, lease and operate its properties and assets and to conduct its business as now being conducted;
and (ii) has all requisite legal and corporate power to execute and deliver this Agreement, and to carry out and perform its obligations
hereunder. All corporate actions on the part of the Company, its directors and shareholders, necessary for the authorization, execution,
delivery and performance of this Agreement and the performance of the Company’s obligations hereunder, have been taken. The execution
and the delivery of this Agreement and the consummation of the transactions contemplated hereby, will not violate any applicable law
or conflict with, or result in a breach of any agreement or other arrangement to which the Company is a party or by which it is bound.

 

2.2.
This Agreement constitutes the valid and binding obligation of the Company, legally enforceable against the Company in accordance with
its terms, except as such enforceability may be limited by (i) bankruptcy, insolvency, reorganization, moratorium and other similar laws
relating to or affecting creditors generally, or by general equity principles, and (ii) laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies.

 

2.3.
The authorized share capital of the Company consists of 500,000,000 Class A ordinary shares, par value US$0.0001 per share, 50,000,000
Class B ordinary shares, par value US$0.0001 per share, and 5,000,000 preference shares, par value US$0.0001 per share.

 

    	 

     

    

 

3.
Representations and Warranties of the Purchaser.

 

The
Purchaser hereby represents and warrants to the Company as follows:

 

3.1.
It has all requisite legal and corporate power to execute and deliver this Agreement, and to carry out and perform its obligations hereunder.
All corporate actions on the part of the Purchaser, its managers and partners, necessary for the authorization, execution, delivery and
performance of this Agreement and the performance of the Purchaser’s obligations hereunder, have been taken. The execution and
the delivery of this Agreement and the consummation of the transactions contemplated hereby, will not violate any applicable law or conflict
with, or result in a breach of any agreement or other arrangement to which the Purchaser is a party or by which it is bound.

 

3.2.
This Agreement constitutes a valid and legally binding obligation of the Purchaser, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, and other laws of general application affecting enforcement of creditors’ rights generally, and (ii)
as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

3.3.
The Purchaser acknowledges that the Purchased Shares it is purchasing subject to the terms of this Agreement are characterized as “restricted
securities” under the U.S. federal securities laws in as much as they are being acquired from the Company in a transaction not
involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under
the U.S. Securities Act of 1933, as amended (the “Act”), only in certain limited circumstances. In this connection,
the Investor represents that it is familiar with Rule 144 under the Act, as presently in effect, and understands the resale limitations
imposed thereby and by the Act.

 

3.4.
It is understood that certificates evidencing the Purchased Shares (if any) may bear one or all of the following legends or similar legend:

 

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED
OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT OR AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT.”

 

4.
Miscellaneous.

 

4.1.
Governing Law. This Agreement shall be governed by the laws of the State of Israel, regardless of any applicable conflict of laws
provisions; and the competent courts of the Tel-Aviv-Jaffa, Israel, will have the exclusive jurisdiction with respect to any conflict
arising in connection herewith.

 

4.2.
Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties hereto with regard
to the subjects hereof, and supersedes any and all prior agreements and understandings of the parties concerning such subject matter.
Neither this Agreement nor any term hereof may be amended, waived, discharged, or terminated other than by a written instrument signed
by both parties hereto.

 

    	2

     

    

 

4.3.
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the party
actually executing such counterpart, and all of which together shall constitute one and the same instrument.

 

4.4.
Notices, etc. All notices and other communications required or permitted hereunder
shall be in writing and shall be deemed effectively given on the earliest of the following: (a) the date of personal delivery; (b) one
(1) business day after transmission by facsimile, addressed to the other party at its facsimile number, with confirmation of transmission;
(c) five (5) business day after deposit with a return receipt express courier; or (d) seven (7) business days after deposit in local
mail by registered or certified mail. All notices not delivered personally or by facsimile will be sent with postage and/or other charges
prepaid and properly addressed at the address as either party shall have notified its counterpart.

 

[Signatures
to Follow]

 

    	3

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Share Purchase Agreement as of the date first above written.

 

	Finnovate
    Acquisition Corp.  	 	Finnovate
    Sponsor L.P. 
	 	 	 
	 	 	 	By:

    
	 Finnovate Sponsor LLC, its general partner
	 	 	 	 	 
	By:	 /s/ David Gershon 	 	By:	 /s/ David Gershon 
	Name:	David
Gershon
	 	Name:	David
    Gershon

    

	Title:	Chairman
    of the Board and CEO	 	Title:	Managing
    Member

 

    	4Exhibit
10.7.1

 

PRIVATE
WARRANTS PURCHASE AGREEMENT

 

THIS
PRIVATE WARRANTS PURCHASE AGREEMENT, dated as of [___], 2021 (as it may from time to time be amended, this “Agreement”),
is entered into by and between Finnovate Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Finnovate
Sponsor L.P., a Delaware limited partnership (the “Purchaser”).

 

RECITALS

 

WHEREAS,
the Company intends to consummate an initial public offering (the “Public Offering”) of the Company’s units (the “Units”),
each Unit consisting of one Class A ordinary share of the Company, par value $0.0001 per share (each, an “Ordinary Share”),
and three-quarters (3/4) of one warrant (a “Warrant”) (each whole Warrant entitles the holder to purchase one Ordinary Share
at a price of $11.50 per share); and

 

WHEREAS,
the Purchaser has agreed to purchase an aggregate of 7,400,000 (or up to 8,243,038 if the underwriters’ over-allotment option in
connection with the Public Offering is exercised in full) Warrants (the “Sponsor Warrants”).

 

NOW
THEREFORE, in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section
1. Authorization, Purchase and Sale; Terms of the Sponsor Warrants.

 

(a)
Authorization of the Sponsor Warrants. The Company has duly authorized the issuance and sale of the Sponsor Warrants to the Purchaser.

 

(b)
Purchase and Sale of the Sponsor Warrants.

 

(i)
On the date of the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and
the Company (the “Initial Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase
from the Company, 7,400,000 Sponsor Warrants at a price of $1.00 per Sponsor Warrant for an aggregate purchase price of $7,400,000 (the
“Purchase Price”), which shall be paid by wire transfer of immediately available funds to the Company at least one day prior
to the Initial Closing Date in accordance with the Company’s wiring instructions. On the Initial Closing Date, following the payment
by the Purchaser of the Purchase Price by wire transfer of immediately available funds to the Company, the Company, at its option, shall
deliver a certificate evidencing the Sponsor Warrants purchased on such date, duly registered in the Purchaser’s name to the Purchaser,
or effect such delivery in book-entry form.

 

    	 

    	 

    

 

(ii)
On the date of any consummation of the closing of the over-allotment option in connection with the Public Offering or on such earlier
time and date as may be mutually agreed by the Purchaser and the Company (each such date, an “Over-allotment Closing Date,”
and each Over-allotment Closing Date (if any) and the Initial Closing Date being sometimes referred to herein as a “Closing Date”),
the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to an aggregate of 843,038 Sponsor
Warrants, in the same proportion as the amount of the option that is then so exercised, at a price of $1.00 per Sponsor Warrant for an
aggregate purchase price of up to $843,038 (if the over-allotment option in connection with the Public Offering is exercised in full)
(the “Over-allotment Purchase Price”), which shall be paid by wire transfer of immediately available funds to the Company
at least one day prior to the Over-allotment Closing Date in accordance with the Company’s wiring instructions. On the Over-allotment
Closing Date, following the payment by the Purchaser of the Over-allotment Purchase Price by wire transfer of immediately available funds
to the Company, the Company shall, at its option, deliver a certificate to the Purchaser evidencing the Sponsor Warrants purchased on
such date duly registered in the Purchaser’s name or effect such delivery in book-entry form.

 

(c)
Terms of the Sponsor Warrants.

 

(i)
Each Sponsor Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in
connection with the Public Offering (a “Warrant Agreement”), and shall be subject to the terms of a letter agreement, dated
as of the date hereof, to be entered into by the Company, the Purchaser and the other parties thereto, in connection with the Public
Offering.

 

(ii)
At the time of, or prior to, the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement
(the “Registration Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser
relating to the Sponsor Warrants and the Ordinary Shares underlying the Sponsor Warrants.

 

(iii)
The Purchaser hereby agrees not to transfer, assign or sell any of the Sponsor Warrants, , and the Ordinary Shares underlying the Sponsor
Warrants, until after the Company’s completion of its initial business combination transaction. The foregoing transfer restrictions
shall not apply to transfers by the Purchaser or by the recipient of any below-described transfer (such recipient, a “Permitted
Transferee”):

 

(a)
to the Company’s officers or directors, any affiliates or family members of the Company’s officers or directors, any members
of the Purchaser, or any affiliates of the Purchaser;

 

(b)
in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which
is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization;

 

(c)
in the case of an individual, by virtue of laws of descent and distribution upon death of the individual;

 

    	2

    	 

    

 

(d)
in the case of an individual, pursuant to a qualified domestic relations order;

 

(e)
by private sales or transfers made in connection with the consummation of a business combination at prices no greater than the price
at which the securities were originally purchased;

 

(f)
in the event of the liquidation of the Company prior to the Company’s completion of its initial business combination;

 

(g)
by virtue of the laws of the Cayman Islands or the Purchaser’s exempted limited partnership agreement, as amended, upon liquidation
of the Purchaser; or

 

(h)
in the event of the Company’s completion of a liquidation, merger, amalgamation, share exchange, reorganization or other similar
transaction which results in all of its shareholders having the right to exchange their Ordinary Shares for cash, securities or other
property subsequent to the Company’s completion of its initial business combination;

 

provided,
however, that except with the Company’s prior consent, in the case of clauses (a) through (e), or (g), above, the Permitted Transferee
must enter into a written agreement agreeing to be bound by these transfer restrictions and by the same agreements entered into by the
Purchaser with respect to the Sponsor Warrants (including provisions relating to voting, the trust account and liquidation distributions,
as described in the prospectus forming a part of the Company’s registration statement on Form S-1).

 

Section
2. Representations and Warranties of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase
the Sponsor Warrants, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive
each Closing Date) that:

 

(a)
Organization and Corporate Power. The Company is an exempted company duly incorporated, validly existing and in good standing under the
laws of the Cayman Islands and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably
be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses
all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

(b)
Authorization; No Breach.

 

(i)
The execution, delivery and performance of this Agreement and the Sponsor Warrants have been duly authorized by the Company as of the
Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance with its terms. Upon
issuance in accordance with, and payment pursuant to, the terms of this Agreement and the Warrant Agreement, the Sponsor Warrants contained
therein will constitute valid and binding obligations of the Company, enforceable in accordance with their terms as of each Closing Date,
and the Sponsor Warrants will be duly issued.

 

    	3

    	 

    

 

(ii)
The execution and delivery by the Company of this Agreement, the issuance and sale of the Sponsor Warrant, , the issuance of the Ordinary
Shares upon exercise of the Sponsor Warrants and the fulfillment, of and compliance with, the respective terms hereof and thereof by
the Company, do not and will not as of each Closing Date (A) conflict with or result in a breach of the terms, conditions or provisions
of, (B) constitute a default under, (C) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s
share capital or assets under, (D) result in a violation of, or (E) require any authorization, consent, approval, exemption or other
action by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to, the amended
and restated memorandum and articles of association of the Company (in effect on the date hereof or as may be amended prior to completion
of the contemplated Public Offering), or any material law, statute, rule or regulation to which the Company is subject, or any agreement,
order, judgment or decree to which the Company is subject, except for any filings required after the date hereof under federal or state
securities laws.

 

(c)
Title to Securities. Upon issuance in accordance with, and payment pursuant to, and registration in the register of members of the Company,
the terms hereof and the Warrant Agreement, the Ordinary Shares issuable upon exercise of the Sponsor Warrants will be duly and validly
issued, fully paid and non-assessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement,
the Purchaser will have good title to the Sponsor Warrants, including the Ordinary Shares issuable upon exercise of such Sponsor Warrants,
free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under the other
agreements contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and (iii) liens, claims or encumbrances
imposed due to the actions of the Purchaser.

 

(d)
Governmental Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority
is required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company
of any other transactions contemplated hereby.

 

Section
3. Representations and Warranties of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue and
sell the Sponsor Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties
shall survive each Closing Date) that:

 

(a)
Organization and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions
contemplated by this Agreement.

 

(b)
Authorization; No Breach.

 

(i)
This Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

    	4

    	 

    

 

(ii)
The execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser
does not and shall not as of each Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions or provisions
of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.

 

(c)
Investment Representations.

 

(i)
The Purchaser is acquiring the Sponsor Warrants, and upon exercise of the Sponsor Warrants, the Ordinary Shares issuable upon such exercise
(collectively, the “Securities”), for the Purchaser’s own account, for investment purposes only and not with a view
towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii)
The Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under the Securities
Act of 1933, as amended (the “Securities Act”).

 

(iii)
The Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and
the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv)
The Purchaser decided to enter into this Agreement not as a result of any general solicitation or general advertising within the meaning
of Rule 502(c) under the Securities Act.

 

(v)
The Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to
ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities
involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.

 

(vi)
The Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on
or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the
Purchaser nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

(vii)
The Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (1) in a registered transaction or (2) sold in reliance on
an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any
other person is under any obligation to register the resale of the Securities under the Securities Act or any state securities laws or
to comply with the terms and conditions of any exemption thereunder. In this regard, the Purchaser understands that the Securities and
Exchange Commission (the “SEC”) has taken the position that promoters or affiliates of a blank check company and their transferees,
both before and after a “business combination”, are deemed to be “underwriters” under the Securities Act when
reselling the securities of a blank check company. Based on that position, Rule 144 adopted pursuant to the Securities Act would not
be available for resale transactions of the Securities despite technical compliance with the requirements of such Rule, and the Securities
can be resold only through a registered offering or in reliance upon another exemption from the registration requirements of the Securities
Act.

 

    	5

    	 

    

 

(viii)
The Purchaser has such knowledge and experience in financial and business matters, knows of the high degree of risk associated with investments
in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment
in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an
indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have
no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can
afford a complete loss of its investments in the Securities.

 

Section
4. Conditions of the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for the Sponsor Warrants are
subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Company contained in ‎Section 2 shall be true and correct
at and as of such Closing Date as though then made.

 

(b)
Performance. The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by it on or before such Closing Date.

 

(c)
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

(d)
Warrant Agreement. The Company shall have entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Purchaser.

 

Section
5. Conditions of the Company’s Obligations. The obligations of the Company to the Purchaser under this Agreement are subject to
the fulfillment, on or before each Closing Date, of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Purchaser contained in ‎Section 3 shall be true and correct
at and as of such Closing Date as though then made.

 

    	6

    	 

    

 

(b)
Performance. The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by the Purchaser on or before such Closing Date.

 

(c)
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

(d)
Warrant Agreement. The Company shall have entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Company.

 

Section
6. Termination. This Agreement may be terminated at any time after December 31, 2021 upon the election by either the Company or the Purchaser
upon written notice to the other party if the closing of the Public Offering does not occur prior to such date.

 

Section
7. Survival of Representations and Warranties. All of the representations and warranties contained herein shall survive each Closing
Date.

 

Section
8. Definitions. Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the registration
statement on Form S-1 the Company has filed with the SEC, under the Securities Act.

 

Section
9. Miscellaneous.

 

(a)
Successors and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or
on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether
so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other
than assignments by the Purchaser to affiliates thereof.

 

(b)
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall
be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

(c)
Counterparts. This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of
more than one party, but all such counterparts taken together shall constitute one and the same agreement.

 

(d)
Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute
a substantive part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather
than by limitation.

 

(e)
Governing Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall
be construed in accordance with the internal laws of the State of New York.

 

(f)
Amendments. This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed
by all parties hereto.

 

[Signature
Page Follows]

 

    	7

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	COMPANY:	 
	 	 
	FINNOVATE
    ACQUISITION CORP.	 
	 	 	 
	By:	/	 
	Name:
    	 	 
	Title:
    	             	 
	 	 	 
	PURCHASER:	 
	 	 	 
	FINNOVATE
    SPONSOR L.P.	 
	 	 	 
	By:
    	 	 
	Name:
    	 	 
	Title:
    	 	 

 

[SIGNATURE
PAGE TO SPONSOR PRIVATE WARRANTS PURCHASE AGREEMENT]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]